Venkat Krishnamurthy

Background

About Venkat Krishnamurthy

RNA Therapeutics| Oligonucleotide| CMC|mRNA| Gene Editing| Lipid Nanoparticles & Non-Viral Gene deliveryA highly experienced scientific leader with over 15 years of experience in RNA Therapeutics (big and small pharma) and academia in Oligonucleotide chemistry/siRNA based therapeutics, Gene Editing, Lipid nanoparticles and other delivery approaches for mRNA, CRISPR-Cas Delivery. Key competencies include- chemistry, formulation and delivery expertise of oligonucleotide/RNA therapeutics• Proven track record – successfully led delivery chemistry and formulation of siRNA, mRNA, oligonucleotides and gene editing programs from discovery to clinic- oversee a team of scientists for Lipid Nanoparticle (LNPs) and other delivery strategy (ex, GalNAc) for nucleic acid delivery (ex, mRNA, therapeutic genome editing etc,)- Successfully managed direct reports and scientific reports across US, UK and Sweden to drive oligonucleotide based therapeutics to clinic.• Successfully led cross functional teams to deliver key milestone on multiple high priority projects.• Highly experienced in due diligence and working with external partners. Successfully evaluated and built multiple partnerships and collaborations with industrial and academic partners.• Successfully led External Innovation and technology scouting• Proven scientific and innovative track record of over 25 publications and patents including first author Nature publication and NIH grant